eIF3M inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the eukaryotic translation initiation factor 3 subunit M (eIF3M). eIF3M is a component of the eIF3 complex, which is a crucial player in the initiation phase of eukaryotic translation. The eIF3 complex is the largest and most complex of the translation initiation factors, composed of multiple subunits, including eIF3M. This complex plays a critical role in the recruitment of the small ribosomal subunit to the mRNA, the scanning of the mRNA for the start codon, and the assembly of the translation machinery. Inhibiting eIF3M can disrupt the overall function of the eIF3 complex, thereby impeding the translation initiation process. This makes eIF3M inhibitors important tools in research for studying the specific role of this subunit in translation and its broader impact on protein synthesis.
The study of eIF3M inhibitors provides valuable insights into the mechanistic aspects of translation initiation. By selectively inhibiting eIF3M, researchers can dissect the specific contributions of this subunit to the eIF3 complex's function and its interaction with other components of the translation machinery. This approach allows scientists to explore how eIF3M influences the regulation of gene expression at the translational level, as well as its involvement in various cellular processes that depend on efficient protein synthesis. Furthermore, eIF3M inhibitors can help identify potential regulatory networks that modulate the activity of the eIF3 complex, offering a deeper understanding of how cells control protein production under different physiological conditions. Overall, eIF3M inhibitors are essential tools for advancing our knowledge of translation initiation and the complex molecular mechanisms that govern this fundamental process in eukaryotic cells.
Items 11 to 14 of 14 total
Schermo:
Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
L'inibizione della topoisomerasi I da parte della camptotecina può causare danni al DNA, il che potrebbe portare a una minore attenzione ai processi di RNAi e quindi a una minore espressione di eIF2C2. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Inibendo Hsp90, la geldanamicina può destabilizzare le proteine associate all'RNAi, il che potrebbe comportare una diminuzione della stabilità o della sintesi di eIF2C2. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Un composto naturale isolato dalla pianta Aglaia foveolata, noto per la sua potente inibizione di EIF4AI. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Un altro composto naturale presente in diverse piante, come il genere Aglaia, con una forte attività inibitoria di EIF4AI. |